Workflow automation platforms have emerged as a major AI subsector, with startups developing tools that can plan and execute tasks autonomously. The focus is rapidly expanding into physical and scientific domains, driven by breakthrough computing advancements.

Scientists are increasingly leveraging AI as a discovery tool across diverse fields, including clean energy materials and medical therapeutics development. This shift is fueling substantial investment activity. European advanced materials startups have already secured €3bn this year, compared to just €1.6bn for the entire previous year.

Drug discovery startups have similarly attracted €4bn in funding this year, positioning themselves to exceed last year's total of €4.7bn. Investor enthusiasm is expected to intensify as AI capabilities continue advancing.

Sifted consulted industry experts to examine how AI operates in real-world environments spanning science and computing sectors, exploring the implications for future technological development.